CATALOGO DEI PRODOTTI DELLA RICERCA

CETTO, Gianluigi
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 7.149
NA - Nord America 6.917
AS - Asia 4.351
SA - Sud America 694
AF - Africa 56
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 5
Totale 19.182
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.830
RU - Federazione Russa 2.480
SG - Singapore 1.842
GB - Regno Unito 1.576
CN - Cina 1.479
SE - Svezia 611
BR - Brasile 566
IT - Italia 533
FR - Francia 459
IE - Irlanda 445
FI - Finlandia 410
HK - Hong Kong 374
DE - Germania 358
VN - Vietnam 200
KR - Corea 156
UA - Ucraina 105
CA - Canada 52
IN - India 48
AR - Argentina 42
TR - Turchia 42
BE - Belgio 36
IR - Iran 32
JP - Giappone 31
BD - Bangladesh 28
MX - Messico 23
EC - Ecuador 20
ES - Italia 20
ZA - Sudafrica 20
IL - Israele 19
NL - Olanda 19
ID - Indonesia 17
PL - Polonia 16
IQ - Iraq 15
LT - Lituania 14
VE - Venezuela 14
CO - Colombia 13
MA - Marocco 12
UZ - Uzbekistan 11
CL - Cile 10
EG - Egitto 10
AT - Austria 9
CZ - Repubblica Ceca 9
PY - Paraguay 9
CH - Svizzera 8
NP - Nepal 8
PK - Pakistan 8
UY - Uruguay 8
AU - Australia 7
LV - Lettonia 7
RO - Romania 7
AE - Emirati Arabi Uniti 6
PE - Perù 6
AL - Albania 5
AZ - Azerbaigian 5
BO - Bolivia 4
EU - Europa 4
PT - Portogallo 4
SA - Arabia Saudita 4
AM - Armenia 3
JM - Giamaica 3
JO - Giordania 3
KG - Kirghizistan 3
SC - Seychelles 3
SK - Slovacchia (Repubblica Slovacca) 3
TW - Taiwan 3
BG - Bulgaria 2
BH - Bahrain 2
BY - Bielorussia 2
DK - Danimarca 2
GR - Grecia 2
GY - Guiana 2
HN - Honduras 2
KE - Kenya 2
ML - Mali 2
NI - Nicaragua 2
NO - Norvegia 2
OM - Oman 2
PH - Filippine 2
PS - Palestinian Territory 2
PW - Palau 2
RS - Serbia 2
SN - Senegal 2
TT - Trinidad e Tobago 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AO - Angola 1
CG - Congo 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EE - Estonia 1
ET - Etiopia 1
HU - Ungheria 1
KW - Kuwait 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
ME - Montenegro 1
NZ - Nuova Zelanda 1
PA - Panama 1
PR - Porto Rico 1
TH - Thailandia 1
Totale 19.180
Salva come PNG Salva come JPEG
Città #
Jacksonville 1.418
Southend 1.350
Chandler 801
Singapore 779
Moscow 772
Dallas 601
Ashburn 475
Woodbridge 446
Dublin 444
Hong Kong 369
Ann Arbor 296
Houston 288
Beijing 205
Lawrence 163
Princeton 163
Wilmington 153
New York 136
Los Angeles 135
Nanjing 119
Jinan 115
The Dalles 111
Shenyang 109
Hebei 89
Buffalo 87
Milan 79
Tianjin 79
Ho Chi Minh City 78
São Paulo 56
Zhengzhou 53
Helsinki 51
Ningbo 51
Boardman 49
Haikou 44
Hanoi 44
Nanchang 44
Changsha 42
Hangzhou 42
Sindelfingen 41
Santa Clara 40
Munich 38
Brussels 35
Taizhou 34
Redondo Beach 33
Verona 33
Jiaxing 31
Turku 31
Lancaster 27
Tokyo 27
Norwalk 25
Columbus 24
Guangzhou 24
Rio de Janeiro 24
Falls Church 23
Seattle 23
Fairfield 22
Montreal 22
Rome 22
Taiyuan 21
Chicago 20
Brooklyn 19
Fuzhou 18
Chennai 16
Philadelphia 16
Denver 15
Toronto 15
Belo Horizonte 13
Council Bluffs 13
Lanzhou 13
Phoenix 13
San Francisco 13
Warsaw 13
Brasília 12
Kent 12
London 12
Mexico City 12
Parma 12
Atlanta 11
Boston 11
Falkenstein 11
Poplar 11
Stockholm 11
Amsterdam 10
Curitiba 10
Guarulhos 10
Tashkent 10
Dearborn 9
Auburn Hills 8
Campinas 8
Johannesburg 8
Montevideo 8
Napoli 8
Orem 8
Redwood City 8
Cambridge 7
Istanbul 7
Manaus 7
Nuremberg 7
San Diego 7
Seoul 7
Zanjan 7
Totale 11.402
Salva come PNG Salva come JPEG
Nome #
Il Formestone (4-Idrossiandrostenedione-LentaronR) nel trattamento di pazienti con cr. mammario metastatico. 280
Acute lymphoblastic leukaemia after radiotherapy and adjuvant chemotherapy (CMF) for breast cancer. 233
[Lung diseases during the course of systemic diseases: current clinico-radiological problems (proceedings)] 223
Significato prognostico dell'indice di proliferazione cellulare nel carcinoma mammario. 214
Alpha-interferon activated cytotoxic lymphocytes in hairy cell leukemia patients: evaluation of cytotoxic events 206
Anti PSCA Monoclonal Antibody and scFv-Fragment for Immunotherapy of Prostate, Pancreatic and Bladder Carcinoma 205
Alpha-interferon activates the natural killer system in patients with hairy cell leukemia 192
Characterization of a new anti PSCA monoclonal antibody and scFv fragment for diagnosis and immunotherapy of prostate, pancreatic and bladder carcinoma. 192
Pseudomonas septicaemia. A review of 60 cases observed in a university hospital 191
Renal toxicity and osteonecrosis of the jaw in cancer patients treated with bisphosphonates: a long-term retrospective analysis. 190
Gamma Knife radiosurgery in brain metastases from testicular tumors 188
A feasibility study for an hospital-based breast cancer registry. 185
Combination of chemotherapy and radiotherapy improves the cure rate in primary extranodal lymphomas of the head and neck (PLHN) 177
bcl-2 but not p53 expression is associated with resistance to chemotherapy in advanced breast cancer 177
Soluble interleukin-2 receptors in the sera of patients with hairy cell leukemia: relationship with the effect of recombinant alpha-interferon therapy on clinical parameters and natural killer in vitro activity 173
Monoterapia empirica con ceftazidime nelle infezioni di pazienti neutropenici affetti da emopatie maligne 173
Ingegnerizzazione di un vettore per espressione di frammenti anticorpali (scFv) biotinilati in procarioti, purificazione ed analisi funzionale 171
Production of a biotinylated anti-PSMA single-chain antibody fragment (scFv) for imaging and radioimmunotherapy 169
Chirurgia e chemioterapia nel trattamento dei linfomi gastrici primitivi: revisione casistica 167
Analisi di linkage in famiglie con carcinoma mammario ereditario. 167
Primary extranodal lymphomas of Waldeyer's ring, stage IE and IIE: Long-term survival after chemotherapy combined with radiotherapy 166
Current trends in hematopoietic stem cell transplantation in Europe 164
A phase II study of induction chemotherapy with gemcitabine (G) and cisplatin (P) in locally advanced non-small cell lung cancer: interim analysis 164
Postoperative chemotherapy increases the disease-free survival rate in primary gastric lymphomas stage IE and IIE 163
[Idiopathic aneurysm of the right ventricle. Report of a case] 162
Produzione e validazione preclinica di un anticorpo anti-PSMA per diagnostica ed immunotargeting 162
Establishment and characterization of a new human melanoma cell line (HU 214) with a high growth potential and stable properties 160
Estrogen receptors in 699 primary breast cancers: a comparison of immunohistochemical and biochemical methods. 158
Analisi immunoistochimica per la ricerca di micrometastasi osteo midollari nel carcinoma mammario. 156
Generazione di nuovi anticorpi anti prostate stem cell antigen (PSCA) e loro caratterizzazione al fine di un futuro utilizzo nella terapia e nella diagnosi dei carcinomi prostatico, pancreatico e della vescica 154
A good death for cancer patients:still a dream? 149
Comportamento dell'ACE e del CEA in pazienti affetti da carcinoma polmonare. 148
Terminal transferase expression in relapsed acute myeloid leukaemia 147
Virtual colonoscopy in the surveillance of suspected HNPCC carriers: a preliminary study 147
Anemia, cancro e chemioterapia antiblastica. 146
Attività di un Registro Tumori di Patologia Mammaria su base ospedaliera. 146
High pathological response rate in locally advanced esophageal cancer after neoadjuvant combined modality therapy: dose finding of a weekly chemotherapy schedule with protracted venous infusion of 5-fluorouracil and dose escalation of cisplatin, docetaxel and concurrent radiotherapy. 145
Cisplatin pharmacokinetics in elderly patients 143
Cytofluorymetric evaluation of DNA ploidy in lung cancer: a broncoscopic study 143
Detection of normal and malignant megakaryocytes by anti beta-thromboglobulin serum. An immunofluorescence study 142
Caratterizzazione di una nuova linea cellulare di melanoma umano. 142
Attività proliferativa del carcinoma mammario: studio su 329 pazienti. 142
Mediastinal large-B-cell lymphoma with sclerosis: a clinical study of 21 patients 141
Clinical evaluation of 51 patients with small cell lung cancer (SCLC). 141
Prognostic significance of estrogen receptors in 405 primary breast cancers: a comparison of immunohistochemical and biochemical methods 139
Immuno-histological analysis of bone marrow involvement in lymphoproliferative disorders 139
Pathological,biological and clinical characteristics and surgical mamagement of ederly women with brest cancer 139
Gram-negative septicemia in patients with hematologic malignancies 139
Comparative analysis of three different methods in detecting breast cells in bone marrow. 139
Anemia, cancro e chemioterapia antiblastica. 138
Adjuvant chemotherapy with high dose epirubicin and cyclophosphamide (EC) vs cyclophosphamide, methotrexate, fluorouracil (CMF) in high risk premenopausal breast cancer patients. 97. 137
Cation content and membrane deformability of heterozygous beta-thalassaemic red blood cells 136
A phase II study of gemcitabine (GEM) and vindesine (VDS) in elderly or poor performance patients with unresectable non small cell lung cancer (NSCLC): final results. 136
The detection of breast cancer (b.c.) cells in bone marrow (b.m.): comparative analysis of sensitivity and specificity of three different methods. 134
Adjuvant chemotherapy with high-dose epirubicin and cyclophosphamide vs CMF in high-risk premenopausal breast cancer patients (pts). Prospective randomized phase III trial. 133
Efficacy of chemotherapy in two cases of extranodal retroperitoneal germ cell tumors. 132
Analisi puntiforme dei valori sierici del CA 15.3 e del CEA in pazienti con carcinoma della mammella. 132
Caratterizzazione fenotipica di cloni ottenuti da una linea cellulare di melanoma umano. 131
Ricerca immunoistochimica di micrometastasi osteo midollari in 33 pazienti portatrici di carcinoma della mammella. 131
La terapia ad alte dosi nel carcinoma mammario metastatico e nella mastite carcinomatosa. 130
Comparative analysis of three different techniques in detecting breast cancer (b.c.) cells in bone marrow (b.m.). 130
Use of the ratio of time to progression following first and second line therapy to document the activity of the combination of oxaliplatin with 5-fluorouracil in the treatment of colorectal carcinoma 127
Fanconi's anaemia in adults: study of three families 124
Evoluzione del concetto di dose in chemioterapia: basi teoriche e modelli matematici. Cetto G.L., Molino A. in: “L’intensità di dose in Oncologia Medica”. G.Bonadonna, G.Robustelli della Cuna eds., Edimes, Progressi in Oncologia Clinica 4: pag. 11-22, Pavia 1995 123
Dosaggio della NSE in pazienti affetti da tumori di origine neuroectodermica. 123
Cisplatin pharmacokinetics using a five-day schedule during repeated courses of chemotherapy in germ cell tumors 122
Comparison of two different methods for the determination of estrogen receptors (ER) in breast cancer (b.c.). 122
Correlazione tra trattamento adiuvante (chemioterapia e/o ormonoterapia), dosaggio RE e RPg, N , comparsa di metastasi in 150 pazienti con carcinoma mammario. 122
Positive immunostaining with MLuC1 of bone marrow aspirate predicts poor outcome in patients with small-cell lung cancer 121
Adjuvant chemotherapy with high dose epirubicin and cyclophosphamide (ec) vs cyclophosphamide, methotrexate, fluorouracil (CMF) in high risk premenopausal breast cancer patients (PTS). A prospective randomized trial. E 121
The antiemetic activity of high dose metoclopramide and high dose alizapride in combination with lorazepam in patients receiving chemotherapy 119
Comportamento del CA 15 3 nelle pazienti affette da carcinoma mammario (stadio I III). 119
Estramustine plus docetaxel as second-line therapy in patients with hormone-refractory prostate cancer resistant to docetaxel alone 119
Gemcitabine and continuous infusion of 5-fluorouracil in locally advanced and metastatic pancreatic cancer: a phase I-II study 117
Efficacia antiemetica dell'ondansetron (GR 38032): continuità dell'attività terapeutica. 117
Cisplatin versus carboplatin in combination with mitomycin and vinblastine in advanced non small cell lung cancer 116
Bone marrow micrometastases in 109 breast cancer patients: correlations with clinical and pathological features and prognosis 114
Bone marrow micrometastases in breast cancer patients. 111
Micrometastasi midollari in pazienti con carcinoma mammario operabile: studio su 51 casi. 110
Phase I°/II° trial of recombinant alfha 2 interferon (IFN) and Vinblastine (VBL) in metastatic renal cell cancer (MRCC). 110
Ki-67 e risposta alla chemioterapia nel carcinoma mammario avanzato. 110
Bone metastases from primary cardiac sarcoma: case report 108
Leucemia linfatica acuta dopo radioterapia e chemioterapia adiuvante (CMF) per cr della mammella. 107
Replicative fraction in breast carcinoma. An Immunohistochemical study of 236 cases. 107
New standards in the chemotherapy of metastatic hormone-refractory prostate cancer 105
Estrogen and progesterone receptors in breast cancer: correlation with clinical and pathological features and with prognosis. 105
Estrogen receptors in 699 primary breast cancers: a comparison of immunohistochemical and biochemical methods. 104
Ifosfamide encephalopathy: a case report 103
Gemcitabine (GEM) and Vindesine (VDS) in advanced non-small cell lung cancer (NSCLC): A phase II study in elderly or poor performance status patients 103
Economic aspect of high-dose-chemotherapy (HDC): a clinician’s perspective review 103
Micrometastases in bone marrow: study in 51 breast cancer patients. 102
Comparison of two different methods of evaluating proliferative index in breast cancer. 102
Detection of a soluble form of the receptor for interleukin 2 in the serum of patients with hairy cell leukaemia 101
Chemotherapy for metastatic melanoma 101
Correlation of replicative fraction by Ki67 immunohistochemistry (RF) with clinico pathological features and prognosis in breast cancer (B.C.). 101
Impact of a breast cancer registry on the management of breast cancer patients 100
Neo-adjuvant chemotherapy in non-smallcell lung cancer (SSCLC) 99
Correlations between family history and cancer characteristics in 2256 breast cancer patients. 98
Identification of Clinical Prognostic Factors in Patients with Unknown Primary Tumors Treated with a Platinum-Based Combination 98
Prognostic significance of estrogen and progesterone receptors (RE and PR) in 234 breast cancer patients. 98
Totale 14.111
Salva come PNG Salva come JPEG
Categoria #
all - tutte 61.750
article - articoli 26.578
book - libri 2.675
conference - conferenze 32.497
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 123.500
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021745 0 0 0 0 0 206 16 176 139 11 161 36
2021/20221.469 76 457 13 204 78 37 33 76 64 31 127 273
2022/20232.534 203 216 270 361 345 624 23 141 269 18 45 19
2023/20241.043 39 114 89 113 146 150 39 39 5 48 168 93
2024/20253.050 179 216 96 489 148 56 163 106 508 220 211 658
2025/20265.167 637 529 558 1.372 2.005 66 0 0 0 0 0 0
Totale 19.243